October 11, 2019
- CDER Alert: FDA advises consumers not to use Rompe Pecho cough syrup
- FDA Updates and Press Announcements on NDMA in Zantac (ranitidine)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drug Trials Snapshots: BEOVU
- FDA Drug Shortages
- Asparaginase Erwinia Chrysanthemi (Erwinaze) (Updated - Currently in Shortage)
- Cefazolin Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Ondansetron Hydrochloride Injection (Updated - Currently in Shortage)
- Nalbuphine Hydrochloride Injection (New - Currently in Shortage)
- Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of all Sterile Compounded Drug Products Due to a Lack of Sterility Assurance
- National Drug Code Directory (updated)
- NDC Database Excluded Packages and Products (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario